Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton

Recruiting N/A Interventional Study
Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
24 (estimated)
Sponsor
Albert Einstein Healthcare Network · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance, and quality of life before, during and after an eight-week intervention program. The results will lay the groundwork fo…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Physician diagnosed idiopathic Parkinson's disease 2. All Hoehn and Yahr (H\&Y) stages will be eligible for inclusion in the study 3. Able to consent to participation in the research study 4. Pt agreeable to participate in 45-60 minutes of high intensity (RPE 14-17 for 30 min…
Contacts

Jacqueline Brown, DPT

215-663-6575

Jxb892@jefferson.edu

CONTACT

Kris Ferrara, DPT

215-663-6575

Kristopher.Ferrara@jefferson.edu

CONTACT